La Jolla Institute for Allergy & Immunology:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:La Jolla Institute for Allergy & Immunology - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9345
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
La Jolla Institute for Allergy & Immunology (LIAI) is a biomedical research institute that offers solutions for infectious agents and cancers. The institute provides research on prevention, treatment, and cure of immune system diseases. Its activities include disease research on allergy and asthma, cancer, diabetes, infectious disease, inflammation biology, microbiology and immunology, and RNAi research. LIAI also offers autoimmune research on rheumatoid arthritis, type 1 diabetes, multiple sclerosis and Crohn’s disease, among others. The institute operates through various research centers located across the US. LIAI is headquartered in La Jolla, California, the US.

La Jolla Institute for Allergy & Immunology – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
La Jolla Institute for Allergy & Immunology, Medical Devices Deals, 2012 to YTD 2018 9
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Bioneer Enters Into Research Agreement with La Jolla Institute for Allergy and Immunology 11
La Jolla Institute Enters Into Agreement With Kyowa Hakko Kirin California For Drug Discovery 12
Licensing Agreements 13
Turnstone Biologics Enters into Licensing Agreement with La Jolla Institute for Allergy and Immunology 13
Equity Offering 14
CHIME BioTherapeutics Spin-Off from La Jolla Institute for Allergy and Immunology 14
La Jolla Institute for Allergy & Immunology – Key Competitors 15
La Jolla Institute for Allergy & Immunology – Key Employees 16
La Jolla Institute for Allergy & Immunology – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Government and Public Interest 18
Apr 12, 2018: LJI Researchers are One Step Closer to an Effective Anti-Atherosclerosis Vaccine 18
Product News 19
Oct 26, 2017: Vanderbilt leads international effort to develop universal flu vaccine 19
Jun 20, 2017: San Diego team tests best delivery mode for potential HIV vaccine 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Key Facts 2
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
La Jolla Institute for Allergy & Immunology, Deals By Therapy Area, 2012 to YTD 2018 8
La Jolla Institute for Allergy & Immunology, Medical Devices Deals, 2012 to YTD 2018 9
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Bioneer Enters Into Research Agreement with La Jolla Institute for Allergy and Immunology 11
La Jolla Institute Enters Into Agreement With Kyowa Hakko Kirin California For Drug Discovery 12
Turnstone Biologics Enters into Licensing Agreement with La Jolla Institute for Allergy and Immunology 13
CHIME BioTherapeutics Spin-Off from La Jolla Institute for Allergy and Immunology 14
La Jolla Institute for Allergy & Immunology, Key Competitors 15
La Jolla Institute for Allergy & Immunology, Key Employees 16

List of Figures
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
La Jolla Institute for Allergy & Immunology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
La Jolla Institute for Allergy & Immunology, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[La Jolla Institute for Allergy & Immunology:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Brenntag Canada Inc:企業の戦略的SWOT分析
    Brenntag Canada Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Afrimat Ltd:企業の戦略・SWOT・財務情報
    Afrimat Ltd - Strategy, SWOT and Corporate Finance Report Summary Afrimat Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Showa Shell Sekiyu K.K.:企業の戦略・SWOT・財務情報
    Showa Shell Sekiyu K.K. - Strategy, SWOT and Corporate Finance Report Summary Showa Shell Sekiyu K.K. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • China Merchants Securities Co Ltd (600999):企業の財務・戦略的SWOT分析
    China Merchants Securities Co Ltd (600999) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Checkpoint Systems, Inc.:企業の戦略・SWOT・財務分析
    Checkpoint Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Checkpoint Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • MediWound Ltd (MDWD):医療機器:M&Aディール及び事業提携情報
    Summary MediWound Ltd (MediWound) is a biopharmaceutical company that on develops, manufactures and commercializes novel therapeutics based on its patented proteolytic enzyme technology. Its products address unmet needs in the areas of severe burns, chronic and other hard-to-heal wounds.The company’ …
  • Tsogo Sun Holdings Ltd:企業のM&A・事業提携・投資動向
    Tsogo Sun Holdings Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tsogo Sun Holdings Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Aramark (ARMK):企業の財務・戦略的SWOT分析
    Aramark (ARMK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Yamada Denki Co Ltd:企業の戦略・SWOT・財務分析
    Yamada Denki Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Yamada Denki Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Societe BIC (BB):企業の財務・戦略的SWOT分析
    Societe BIC (BB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sompo Holdings, Inc. (8630):企業の財務・戦略的SWOT分析
    Sompo Holdings, Inc. (8630) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Civica Group Limited:企業の戦略的SWOT分析
    Civica Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Selective Insurance Group, Inc. (SIGI):企業の財務・戦略的SWOT分析
    Selective Insurance Group, Inc. (SIGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • ID Pharma Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary ID Pharma Co Ltd (ID Pharma), formerly DNAVEC Corp is a manufacturer and commercializer of gene medicines. The company develops regenerative medicines, cell therapy, and other bio products. It offers vector platforms such as Sendai virus vector in its drug development process. ID Pharma’s ve …
  • Rapid Pathogen Screening Inc-医療機器分野:企業M&A・提携分析
    Summary Rapid Pathogen Screening Inc (Rapid Pathogen) is a biotechnology company that designs, develops, manufactures and markets point-of-care diagnostic tests. The company uses its patented direct sampling micro-filtration and direct multi-planar chromafiltography technology to develop various tes …
  • Essential Energy Services Ltd (ESN):石油・ガス:M&Aディール及び事業提携情報
    Summary Essential Energy Services Ltd (Essential Energy) is an oil and gas company that offers oilfield services. The company provides coil well services and tool services. Its services include coil tubing, fluid and nitrogen pumping, completion, abandonment, and downhole tools and equipment rental …
  • Armune BioScience Inc:医療機器:M&Aディール及び事業提携情報
    Summary Armune BioScience Inc (Armune BioScience), a subsidiary of Exact Sciences Corp is a medical device development company that develops and commercializes molecular prognostic and diagnostic tests. The company uses genomics and proteomics in cancer to identifying specific sets of genes or prote …
  • Net One Systems Co Ltd (7518):企業の財務・戦略的SWOT分析
    Net One Systems Co Ltd (7518) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Orsted Salg & Service AS:企業の戦略的SWOT分析
    Orsted Salg & Service AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Soitec SA (SOI)-エネルギー分野:企業M&A・提携分析
    Summary Soitec S.A. (Soitec) is a designer and manufacturer of semiconductor materials. The company offers solutions for miniaturizing chips. Its products are used to manufacture chips which are used in smartphones, tablets, computers, IT servers and data centers, electronic components in cars, conn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆